|
1
|
Kristensen BW, Priesterbach-Ackley LP,
Petersen JK and Wesseling P: Molecular pathology of tumors of the
central nervous system. Ann Oncol. 30:1265–1278. 2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Louis DN, Perry A, Wesseling P, Brat DJ,
Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM,
Reifenberger G, et al: The 2021 WHO classification of tumors of the
central nervous system: A summary. Neuro Oncol. 23:1231–1251.
2021.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Smith HL, Wadhwani N and Horbinski C:
Major features of the 2021 WHO classification of CNS tumors.
Neurotherapeutics. 19:1691–1704. 2022.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Singer LS, Feldman AZ, Buerki RA,
Horbinski CM, Lukas RV and Stupp R: The impact of the molecular
classification of glioblastoma on the interpretation of therapeutic
clinical trial results. Chin Clin Oncol. 10(38)2021.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Wood MD, Beadling C, Neff T, Moore S,
Harrington CA, Baird L and Corless C: Molecular profiling of pre-
and post-treatment pediatric high-grade astrocytomas reveals
acquired increased tumor mutation burden in a subset of
recurrences. Acta Neuropathol Commun. 11(143)2023.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Ng WK: Radiation-associated changes in
tissues and tumours. Curr Diagn Pathol. 9:124–136. 2003.
|
|
7
|
Umekawa M, Shinya Y, Hasegawa H, Morshed
RA, Katano A, Shinozaki-Ushiku A and Saito N: Ki-67 labeling index
predicts tumor progression patterns and survival in patients with
atypical meningiomas following stereotactic radiosurgery. J
Neurooncol. 167:51–61. 2024.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Verma N, Cowperthwaite MC, Burnett MG and
Markey MK: Differentiating tumor recurrence from treatment
necrosis: A review of neuro-oncologic imaging strategies. Neuro
Oncol. 15:515–534. 2013.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Smith EJ, Naik A, Shaffer A, Goel M, Krist
DT, Liang E, Furey CG, Miller WK, Lawton MT, Barnett DH, et al:
Differentiating radiation necrosis from tumor recurrence: A
systematic review and diagnostic meta-analysis comparing imaging
modalities. J Neurooncol. 162:15–23. 2023.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Cacciotti C, Lenzen A, Self C and
Pillay-Smiley N: Recurrence patterns and surveillance imaging in
pediatric brain tumor survivors. J Pediatr Hematol Oncol.
46:e227–e232. 2024.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Lebrun L, Gilis N, Dausort M, Gillard C,
Rusu S, Slimani K, De Witte O, Escande F, Lefranc F, D'Haene N, et
al: Diagnostic impact of DNA methylation classification in adult
and pediatric CNS tumors. Sci Rep. 15(2857)2025.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Kuschel LP, Hench J, Frank S, Hench IB,
Girard E, Blanluet M, Masliah-Planchon J, Misch M, Onken J,
Czabanka M, et al: Robust methylation-based classification of brain
tumours using nanopore sequencing. Neuropathol Appl Neurobiol.
49(e12856)2023.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Park JW, Lee K, Kim EE, Kim SI and Park
SH: Brain tumor classification by methylation profile. J Korean Med
Sci. 38(e356)2023.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Lyko F: The DNA methyltransferase family:
A versatile toolkit for epigenetic regulation. Nat Rev Genet.
19:81–92. 2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Lee TG, Kim SY, Kim HR, Kim H and Kim CH:
Radiation induces autophagy via histone H4 lysine 20 trimethylation
in non-small cell lung cancer cells. Anticancer Res. 40:2537–2548.
2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Brandes AA, Franceschi E, Paccapelo A,
Tallini G, De Biase D, Ghimenton C, Danieli D, Zunarelli E, Lanza
G, Silini EM, et al: Role of MGMT methylation status at time of
diagnosis and recurrence for patients with glioblastoma: Clinical
implications. Oncologist. 22:432–437. 2017.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Jin B and Robertson KD: DNA
methyltransferases, DNA damage repair, and cancer. Adv Exp Med
Biol. 754:3–29. 2013.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Ahsan MU, Gouru A, Chan J, Zhou W and Wang
K: A signal processing and deep learning framework for methylation
detection using Oxford Nanopore sequencing. Nat Commun.
15(1448)2024.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Euskirchen P, Bielle F, Labreche K,
Kloosterman WP, Rosenberg S, Daniau M, Schmitt C, Masliah-Planchon
J, Bourdeaut F, Dehais C, et al: Same-day genomic and epigenomic
diagnosis of brain tumors using real-time nanopore sequencing. Acta
Neuropathol. 134:691–703. 2017.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Li H: Minimap2: Pairwise alignment for
nucleotide sequences. Bioinformatics. 34:3094–3100. 2018.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Capper D, Jones DTW, Sill M, Hovestadt V,
Schrimpf D, Sturm D, Koelsche C, Sahm F, Chavez L, Reuss DE, et al:
DNA methylation-based classification of central nervous system
tumours. Nature. 555:469–474. 2018.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Maas SLN, Stichel D, Hielscher T, Sievers
P, Berghoff AS, Schrimpf D, Sill M, Euskirchen P, Blume C, Patel A,
et al: Integrated molecular-morphologic meningioma classification:
A multicenter retrospective analysis, retrospectively and
prospectively validated. J Clin Oncol. 39:3839–3852.
2021.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Santana-Santos L, Kam KL, Dittmann D, De
Vito S, McCord M, Jamshidi P, Fowler H, Wang X, Aalsburg AM, Brat
DJ, et al: Validation of whole genome methylation profiling
classifier for central nervous system tumors. J Mol Diagn.
24:924–934. 2022.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Priesterbach-Ackley LP, Boldt HB, Petersen
JK, Bervoets N, Scheie D, Ulhøi BP, Gardberg M, Brännström T, Torp
SH, Aronica E, et al: Brain tumour diagnostics using a DNA
methylation-based classifier as a diagnostic support tool.
Neuropathol Appl Neurobiol. 46:478–492. 2020.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Ma J, Hong Y, Chen W, Li D, Tian K, Wang
K, Yang Y, Zhang Y, Chen Y, Song L, et al: High copy-number
variation burdens in cranial meningiomas from patients with diverse
clinical phenotypes characterized by hot genomic structure changes.
Front Oncol. 10(1382)2020.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Wang JZ, Nassiri F, Landry AP, Patil V,
Liu J, Aldape K, Gao A and Zadeh G: The multiomic landscape of
meningiomas: A review and update. J Neurooncol. 161:405–414.
2023.PubMed/NCBI View Article : Google Scholar
|
|
27
|
da Silveira MA, Ferreira WAS, Amorim CKN,
Brito JRN, Kayath AS, Sagica FDES and de Oliveira EHC: Meningiomas:
An overview of the landscape of copy number alterations in samples
from an admixed population. J Oncol. 2020(3821695)2020.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Whitehouse JP, Howlett M, Federico A, Kool
M, Endersby R and Gottardo NG: Defining the molecular features of
radiation-induced glioma: A systematic review and meta-analysis.
Neurooncol Adv. 3(vdab109)2021.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Behling F, Barrantes-Freer A, Skardelly M,
Nieser M, Christians A, Stockhammer F, Rohde V, Tatagiba M,
Hartmann C, Stadelmann C and Schittenhelm J: Frequency of BRAF
V600E mutations in 969 central nervous system neoplasms. Diagn
Pathol. 11(55)2016.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Kowalewski A, Durślewicz J, Zdrenka M,
Grzanka D and Szylberg Ł: Clinical relevance of BRAF V600E mutation
status in brain tumors with a focus on a novel management
algorithm. Target Oncol. 15:531–540. 2020.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Attia AS, Hussein M, Issa PP, Elnahla A,
Farhoud A, Magazine BM, Youssef MR, Aboueisha M, Shama M, Toraih E
and Kandil E: Association of BRAFV600E mutation with the
aggressive behavior of papillary thyroid microcarcinoma: A
meta-analysis of 33 studies. Int J Mol Sci.
23(15626)2022.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Zhang S, He S, Zhu X, Wang Y, Xie Q, Song
X, Xu C, Wang W, Xing L, Xia C, et al: DNA methylation profiling to
determine the primary sites of metastatic cancers using
formalin-fixed paraffin-embedded tissues. Nat Commun.
14(5686)2023.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Gull N, Jones MR, Peng PC, Coetzee SG,
Silva TC, Plummer JT, Reyes ALP, Davis BD, Chen SS, Lawrenson K, et
al: DNA methylation and transcriptomic features are preserved
throughout disease recurrence and chemoresistance in high grade
serous ovarian cancers. J Exp Clin Cancer Res.
41(232)2022.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Huntoon K, Toland AMS and Dahiya S:
Meningioma: A review of clinicopathological and molecular aspects.
Front Oncol. 10(579599)2020.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Hergalant S, Saurel C, Divoux M, Rech F,
Pouget C, Godfraind C, Rouyer P, Lacomme S, Battaglia-Hsu SF and
Gauchotte G: Correlation between DNA methylation and cell
proliferation identifies new candidate predictive markers in
meningioma. Cancers (Basel. 14(6227)2022.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Chen CH, Lin YJ, Lin YY, Lin CH, Feng LY,
Chang IY, Wei KC and Huang CY: Glioblastoma primary cells retain
the most copy number alterations that predict poor survival in
glioma patients. Front Oncol. 11(621432)2021.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Yin A, Etcheverry A, He Y, Aubry M,
Barnholtz-Sloan J, Zhang L, Mao X, Chen W, Liu B, Zhang W, et al:
Integrative analysis of novel hypomethylation and gene expression
signatures in glioblastomas. Oncotarget. 8:89607–89619.
2017.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Matsuda T, Kono T, Taki Y, Sakuma I,
Fujimoto M, Hashimoto N, Kawakami E, Fukuhara N, Nishioka H,
Inoshita N, et al: Deciphering craniopharyngioma subtypes:
Single-cell analysis of tumor microenvironment and immune networks.
iScience. 27(111068)2024.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Zhao C, Wang Y, Liu H, Qi X, Zhou Z, Wang
X and Lin Z: Molecular biological features of cyst wall of
adamantinomatous craniopharyngioma. Sci Rep.
13(3049)2023.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Jucá CEB, Colli LM, Martins CS, Campanini
ML, Paixão B, Jucá RV, Saggioro FP, de Oliveira RS, Moreira AC,
Machado HR, et al: Impact of the canonical wnt pathway activation
on the pathogenesis and prognosis of adamantinomatous
craniopharyngiomas. Horm Metab Res. 50:575–581. 2018.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Choudhury A, Magill ST, Eaton CD, Prager
BC, Chen WC, Cady MA, Seo K, Lucas CG, Casey-Clyde TJ, Vasudevan
HN, et al: Meningioma DNA methylation groups identify biological
drivers and therapeutic vulnerabilities. Nat Genet. 54:649–659.
2022.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Bertero L, Mangherini L, Ricci AA, Cassoni
P and Sahm F: Molecular neuropathology: An essential and evolving
toolbox for the diagnosis and clinical management of central
nervous system tumors. Virchows Arch. 484:181–194. 2024.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Lin Y, Dong ZH, Ye TY, Yang JM, Xie M, Luo
JC, Gao J and Guo AY: Optimization of FFPE preparation and
identification of gene attributes associated with RNA degradation.
NAR Genom Bioinform. 6(lqae008)2024.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Zhang P, Lehmann BD, Shyr Y and Guo Y: The
utilization of formalin fixed-paraffin-embedded specimens in high
throughput genomic studies. Int J Genomics.
2017(1926304)2017.PubMed/NCBI View Article : Google Scholar
|
